Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5285928
Max Phase: Preclinical
Molecular Formula: C20H23FN8O9S
Molecular Weight: 570.52
Associated Items:
ID: ALA5285928
Max Phase: Preclinical
Molecular Formula: C20H23FN8O9S
Molecular Weight: 570.52
Associated Items:
Canonical SMILES: Nc1ncnc2c1ncn2[C@@H]1O[C@H](CN(CC[C@H](N)C(=O)O)S(=O)(=O)c2ccc(F)c([N+](=O)[O-])c2)[C@@H](O)[C@H]1O
Standard InChI: InChI=1S/C20H23FN8O9S/c21-10-2-1-9(5-12(10)29(34)35)39(36,37)27(4-3-11(22)20(32)33)6-13-15(30)16(31)19(38-13)28-8-26-14-17(23)24-7-25-18(14)28/h1-2,5,7-8,11,13,15-16,19,30-31H,3-4,6,22H2,(H,32,33)(H2,23,24,25)/t11-,13+,15+,16+,19+/m0/s1
Standard InChI Key: HJCPHTUCSUVWNC-KFAHYOAQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 570.52 | Molecular Weight (Monoisotopic): 570.1293 | AlogP: -1.43 | #Rotatable Bonds: 10 |
Polar Surface Area: 263.15 | Molecular Species: ZWITTERION | HBA: 14 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 17 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 1.90 | CX Basic pKa: 9.09 | CX LogP: -3.78 | CX LogD: -3.78 |
Aromatic Rings: 3 | Heavy Atoms: 39 | QED Weighted: 0.14 | Np Likeness Score: -0.43 |
1. Schwickert M, Zimmermann RA, Habeck T, Hoba SN, Nidoieva Z, Fischer TR, Stark MM, Kersten C, Lermyte F, Helm M, Schirmeister T.. (2023) Covalent S-Adenosylhomocysteine-Based DNA Methyltransferase 2 Inhibitors with a New Type of Aryl Warhead., 14 (6): [PMID:37312859] [10.1021/acsmedchemlett.3c00062] |
Source(1):